NEW IMMUNOSUPPRESSIVE AGENTS FOR PEDIATRIC TRANSPLANTATION

被引：5

作者：

FERRARESSO, M ^{[1
]}

KAHAN, BD ^{[1
]}

机构：

[1] UNIV TEXAS,SCH MED,DEPT SURG,DIV IMMUNOL & ORGAN TRANSPLANTAT,6431 FANNIN,MSB 6 240,HOUSTON,TX 77030

来源：

PEDIATRIC NEPHROLOGY | 1993年 / 7卷 / 05期

关键词：

IMMUNOSUPPRESSIVE AGENTS; TRANSPLANTATION; CYCLOSPORINE;

D O I：

10.1007/BF00852552

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Pediatric transplantation has always been challenging for transplant surgeons. Although the higher immunoreactivity and the faster metabolism showed by this unique population when compared with adults requires a heavy immunosuppressive regimen, the possibility of disrupting the delicate balance of correct psychophysical development calls for a regimen of more selective and less toxic immunosuppressive drugs. In the past decade several new drugs have been investigated and some of them appear to be very promising, although pleiotropic toxicities have not yet been eliminated. An appropriate pharmacokinetic approach and the evaluation of synergistic multi-drug combinations by rigorous mathematical models would lead to highly selective immunosuppressive regimens which may result in virtually no toxicity.

引用

页码：567 / 573

页数：7

共 80 条

[1]

Kahan B.D., Transplantation timeline: mankind's three millennia—one maverick's three decades in the struggle against biochemical individuality, Transplantation, 51, pp. 1-21, (1991)

[2]

Merrill J.P., Murray J.E., Harrison J.H., Guild W.R., Successful homo-transplantation of the human kidney between identical twins, JAMA, 160, pp. 277-281, (1956)

[3]

Starzl T.E., Marchioro T.L., Porter K.A., Faris T.D., Carey T.A., The role of organ transplantation in pediatrics, Pediatr Clin North Am, 13, pp. 381-422, (1966)

[4]

DeShazo C.V., Simmons R.L., Bernstein D.M., DeShazo M.M., Willmart J., Kiellstrand G.M., Najarian J.S., Results of renal transplantation in 100 children, Surgery, 76, pp. 461-468, (1974)

[5]

Lilly J.R., Giles G., Hurwitz R., Schroter G., Takagi H., Gray S., Penn I., Halgrion C.G., Starzl T.E., Renal homotransplantation in pediatric patients, Pediatrics, 47, pp. 548-557, (1971)

[6]

Borel J.F., Feurer C., Gubler H.U., Stahelin H., Biological effects of cyclosporine A: a new antilymphocytic agent, Agents Actions, 6, pp. 468-476, (1976)

[7]

Murray J.E., Merrill J.P., Harrison J.H., Et al., Prolonged survival of human kidney homografts by immunosuppressive drug therapy, N Engl J Med, 268, pp. 1315-1323, (1963)

[8]

Goodwin W.E., Kaufman J.J., Mi M.M., Turner R.D., Glassok R., Goldman R., Maxwell M.M., Human renal transplantation. I. Clinical experiences with 6 cases of renal homotransplantation, J Urol, 89, pp. 13-24, (1963)

[9]

Cosimi A.B., Colvin R.B., Burton R.C., Rubin R., Goldstein G., Kung P.C., Hansen W.P., Delmonico F.L., Russel P.S., Use of monoclonal antibodies to T-cell subset for immunological monitoring and treatment in recipients of renal allografts, N Engl J Med, 305, pp. 308-314, (1981)

[10]

Synder D.S., Unanue E.R., Corticosteroids inhibit immune macrophages Ig expression and interleukin-1 production, J Immunol, 129, pp. 1803-1805, (1982)

← 1 2 3 4 5 6 7 8 →